Mesoporous silica SBA-15 decreases hyperammonemia and affects the gene expression of mitogen-activated protein kinases in the prefrontal cortex of rats with bile duct ligation

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 236

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-23-10_007

تاریخ نمایه سازی: 19 دی 1399

چکیده مقاله:

Objective(s): We aim to examine possible ammonia lowering effects of mesoporous silica SBA-15 in rats after the common bile duct ligation (BDL). We also evaluate the effect of SBA-15 treatments during 28 days of BDL on locomotion and rearing behavior, as well as on the gene expression of Jnk3 and p38alpha (p38α) mitogen-activated protein kinases in the prefrontal cortex (PFC).Materials and Methods: SBA-15 was prepared with the hydrothermal method from the surfactant P123 and tetraethyl orthosilicate (TEOS), and calcined at 550 ºC. Then, the product was characterized by FT-IR, XRD, SEM, and BJH-BET techniques. Male Wistar rats in sham control and a group with BDL received saline but another group with BDL received SBA-15 during 28 days of BDL. We examined all groups of rats weekly for locomotion and rearing behavior; then on day 28, we sacrificed all rats, collected the blood sample, and finally dissected the PFC from the whole brain.Results: The SBA-15 treatments had no effect on locomotion but improved rearing behavior on days 7 and 14 of BDL. Biochemical analysis indicated that the SBA-15 treatments in rats with BDL significantly decreased hyperammonemia. The results also revealed that the SBA-15 treatments in rats with BDL significantly restored the decreased Jnk3 gene expression, and increased the p38α gene expression in the PFC.Conclusion: We conclude that SBA-15 can be used as an ammonia lowering agent in hepatic encephalopathy; however, its improving effects on locomotion and neuroinflammation, as well as signaling molecules in the brain need more investigations.

کلیدواژه ها:

Ammonia c ، Jun Kinase 3 Hepatic encephalopathy Inflammations p38 MAPK SBA ، 15

نویسندگان

Shamseddin Ahmadi

Department of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Iran

Halaleh Ghaderi

Department of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Iran

Nazila Saadati

Department of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Iran

Saadi Samadi

Department of Chemistry, Faculty of Science, University of Kurdistan, Sanandaj, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ...
  • 2. Matoori S, Leroux JC. Recent advances in the treatment ...
  • 3. Thomsen KL, De Chiara F, Rombouts K, Vilstrup H, ...
  • 4. Felipo V. Hepatic encephalopathy: effects of liver failure on ...
  • 5. Parekh PJ, Balart LA. Ammonia and its role in ...
  • 6. Butterworth RF. Pathogenesis of hepatic encephalopathy in cirrhosis: the ...
  • 7. Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza ...
  • 8. Jayakumar AR, Rama Rao KV, Norenberg MD. Neuroinflammation in ...
  • 9. Zemtsova I, Gorg B, Keitel V, Bidmon HJ, Schror ...
  • 10. Prakash R, Mullen KD. Mechanisms, diagnosis and management of ...
  • 11. Sorensen M. Update on cerebral uptake of blood ammonia. ...
  • 12. Khaledi S, Ahmadi S. Hepatic encephalopathy: pathogenesis and treatment ...
  • 13. Soria LR, Brunetti-Pierri N. Targeting autophagy for therapy of ...
  • 14. Wang Y, Zhao Q, Han N, Bai L, Li ...
  • 15. Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti ...
  • 16. Siefker J, Karande P, Coppens MO. Packaging biological cargoes ...
  • 17. Song C, Wang X, Wang Y, Yu H, Cui ...
  • 18. Yang Y, Yu C. Advances in silica based nanoparticles ...
  • 19. Scaramuzzi K, Tanaka GD, Neto FM, Garcia PR, Gabrili ...
  • 20. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht ...
  • 21. Ahmadi S, Poureidi M, Rostamzadeh J. Hepatic encephalopathy induces ...
  • 22. Agusti A, Cauli O, Rodrigo R, Llansola M, Hernandez-Rabaza ...
  • 23. Guo XX, An S, Yang Y, Liu Y, Hao ...
  • 24. Felipo V, Piedrafita B, Barios JA, Agusti A, Ahabrach ...
  • 25. Bachstetter AD, Van Eldik LJ. The p38 MAP kinase ...
  • 26. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow ...
  • 27. Coffey ET. Nuclear and cytosolic JNK signalling in neurons. ...
  • 28. Moriyama M, Jayakumar AR, Tong XY, Norenberg MD. Role ...
  • 29. Panickar KS, Jayakumar AR, Rao KV, Norenberg MD. Ammonia-induced ...
  • 30. Jayakumar AR, Panickar KS, Murthy Ch R, Norenberg MD. ...
  • 31. Irie T, Miyamoto E, Kitagawa K, Maruyama Y, Inoue ...
  • 32. Malaguarnera M, Llansola M, Balzano T, Gómez-Giménez B, Antúnez-Muñoz ...
  • 33. Llansola M, Montoliu C, Cauli O, Hernandez-Rabaza V, Agusti ...
  • 34. Ahmadi S, Faridi S, Tahmasebi S. Calcium-dependent kinases in ...
  • 35. Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh ...
  • 36. Samadi S, Ashouri A, Ghambarian M. Use of CuO ...
  • 37. Zhao D, Feng J, Huo Q, Melosh N, Fredrickson ...
  • 38. Hudson SP, Padera RF, Langer R, Kohane DS. The ...
  • 39. Choi Y, Lee JE, Lee JH, Jeong JH, Kim ...
  • 40. Ahmadi S, Khaledi S. Anxiety in rats with bile ...
  • 41. Samadi S, Ashouri A, Ghambarian M. Use of CuO ...
  • 42. Samadi S, Jadidi K, Khanmohammadi B, Tavakoli N. Heterogenization ...
  • 43. Li Y, Sun N, Li L, Zhao N, Xiao ...
  • 44. Giraldo L, Moreno-Piraján JC. Calorimetric study of mesoporous SBA-15 ...
  • 45. Gao D, Duan A, Zhang X, Chi K, Zhao ...
  • 46. Kosuge K, Sato T, Kikukawa N, Takemori M. Morphological ...
  • 47. Chen C, Zheng H, Xu J, Shi X, Li ...
  • 48. Jiang F, Liu Y, Wang X, Yin Z. pH-sensitive ...
  • 49. Cauli O, Mansouri MT, Agusti A, Felipo V. Hyperammonemia ...
  • 50. Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepatic ...
  • 51. Bosoi CR, Rose CF. Oxidative stress: a systemic factor ...
  • 52. Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic ...
  • 53. Gorg B, Schliess F, Haussinger D. Osmotic and oxidative/nitrosative ...
  • 54. Jiang X, Xu L, Tang L, Liu F, Chen ...
  • 55. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic ...
  • 56. Rose CF. Ammonia-lowering strategies for the treatment of hepatic ...
  • 57. Avruch J. MAP kinase pathways: the first twenty years. ...
  • 58. Kumagae Y, Zhang Y, Kim OJ, Miller CA. Human ...
  • 59. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo ...
  • نمایش کامل مراجع